Abstract:Tuberculosis (TB) is a disease that plagues the frailest members of society. We have developed a family of N-alkyl nitrobenzamides that exhibit promising antitubercular activities and can be considered a structural simplification of known inhibitors of decaprenylphosphoryl-β-D-ribofuranose 2′-oxidase (DprE1), an essential Mycobacterium tuberculosis (Mtb) enzyme and an emergent antitubercular target. Hereby, we report the development of these compounds via a simple synthetic methodology as well as their stability, cytotoxicity, and antitubercular activity. Studying their in vitro activity revealed that the 3,5-dinitro and the 3-nitro-5-trifluoromethyl derivatives were the most active, and within these, the derivatives with intermediate lipophilicities presented the best activities (MIC of 16 ng/mL). Additionally, in an ex vivo macrophage model of infection, the derivatives with chain lengths of six and twelve carbon atoms presented the best results, exhibiting activity profiles comparable to isoniazid. Although the proof is not definite, the assessment of susceptibility over multiple mycobacterial species, together with the structure similarities with known inhibitors of this enzyme, support DprE1 as a likely target of action for the compounds. This idea is also reinforced by the docking studies, where the fit of our more active compounds to the DprE1 binding pocket is very similar to what was observed for known inhibitors like DNB1.

Design, synthesis and antimycobacterial activity of novel nitrobenzamide derivatives

Design, synthesis and antimycobacterial activity of 3,5-dinitrobenzamide derivatives containing fused ring moieties.

Design, synthesis and antitubercular evaluation of benzothiazinones containing an oximido or amino nitrogen heterocycle moiety

Novel Aminopyrimidinyl Benzimidazoles As Potentially Antimicrobial Agents: Design, Synthesis and Biological Evaluation

Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazole hybrids as new antitubercular agents

Design, Synthesis, and Biological Evaluation of Pyrazolo[1,5-a]pyridine-3-carboxamides As Novel Antitubercular Agents.

Design, synthesis and biological activity of N-(amino)piperazine-containing benzothiazinones against Mycobacterium tuberculosis

Design, synthesis and antimycobacterial activity of novel benzothiazinones with improved water solubility

Design, Synthesis and Antimycobacterial Activity of Novel Imidazo[1,2-a]pyridine Amide-Cinnamamide Hybrids.

Design, synthesis, and biological evaluation of m-amidophenol derivatives as a new class of antitubercular agents.

Identification of N-Benzyl 3,5-Dinitrobenzamides Derived from PBTZ169 As Antitubercular Agents.

Synthesis, evaluation and CoMFA/CoMSIA study of nitrofuranyl methyl N-heterocycles as novel antitubercular agents.

Identification of a New Series of Benzothiazinone Derivatives with Excellent Antitubercular Activity and Improved Pharmacokinetic Profiles

Synthesis and Evaluation of Nitrofuranyl Methyl N-heterocycles Derivatives As Novel Antitubercular Agents

Benzothiozinone derivatives with anti-tubercular Activity−Further side chain investigation

Identification of Better Pharmacokinetic Benzothiazinone Derivatives As New Antitubercular Agents.

Synthesis and Biological Evaluation of 2-(3-fluoro-4-nitro Phenoxy)-N-phenylacetamide Derivatives As Novel Potential Affordable Antitubercular Agents

Synthesis, Activity, Toxicity, and In Silico Studies of New Antimycobacterial N-Alkyl Nitrobenzamides

Design and Synthesis of Novel Benzimidazole Derivatives As Anti-Tuberculosis Agents.

Design, Synthesis and Antitubercular Evaluation of Benzothiazinones Containing a Piperidine Moiety

Design, Synthesis and Antimycobacterial Activity of Less Lipophilic Q203 Derivatives Containing Alkaline Fused Ring Moieties.